Učitavanje...
Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?
[Image: see text] The PD-1/PD-L1 interaction has emerged as a significant target in cancer immunotherapy. Current medications include monoclonal antibodies, which have shown impressive clinical results in the treatment of several types of tumors. The cocrystal structure of human PD-1 and PD-L1 is ex...
Spremljeno u:
| Izdano u: | Angew Chem Int Ed Engl |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280658/ https://ncbi.nlm.nih.gov/pubmed/29178534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201710407 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|